<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Nucleic Acids Res</journal-id>
<journal-id journal-id-type="iso-abbrev">Nucleic Acids Res</journal-id>
<journal-id journal-id-type="publisher-id">nar</journal-id>
<journal-title-group>
<journal-title>Nucleic Acids Research</journal-title>
</journal-title-group>
<issn pub-type="ppub">0305-1048</issn>
<issn pub-type="epub">1362-4962</issn>
<publisher>
<publisher-name>Oxford University Press</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30203047</article-id>
<article-id pub-id-type="pmc">6323988</article-id>
<article-id pub-id-type="doi">10.1093/nar/gky814</article-id>
<article-id pub-id-type="publisher-id">gky814</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Database Issue</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Pancan-meQTL: a database to systematically evaluate the effects of genetic variants on methylation in human cancer</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Gong</surname>
<given-names>Jing</given-names>
</name>
<!--<email>gongj@hust.edu.cn</email>-->
<xref ref-type="aff" rid="AFF1">1</xref>
<xref ref-type="corresp" rid="COR1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wan</surname>
<given-names>Hao</given-names>
</name>
<xref ref-type="aff" rid="AFF1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mei</surname>
<given-names>Shufang</given-names>
</name>
<xref ref-type="aff" rid="AFF1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ruan</surname>
<given-names>Hang</given-names>
</name>
<xref ref-type="aff" rid="AFF2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Zhao</given-names>
</name>
<xref ref-type="aff" rid="AFF2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Liu</surname>
<given-names>Chunjie</given-names>
</name>
<xref ref-type="aff" rid="AFF3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Guo</surname>
<given-names>An-Yuan</given-names>
</name>
<xref ref-type="aff" rid="AFF3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Diao</surname>
<given-names>Lixia</given-names>
</name>
<!--<email>ldiao@mdanderson.org</email>-->
<xref ref-type="aff" rid="AFF4">4</xref>
<xref ref-type="corresp" rid="COR1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Miao</surname>
<given-names>Xiaoping</given-names>
</name>
<!--<email>miaoxp@mail.hust.edu.cn</email>-->
<xref ref-type="aff" rid="AFF1">1</xref>
<xref ref-type="corresp" rid="COR1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Han</surname>
<given-names>Leng</given-names>
</name>
<!--<email>leng.han@uth.tmc.edu</email>-->
<xref ref-type="aff" rid="AFF2">2</xref>
<xref ref-type="corresp" rid="COR1"></xref>
</contrib>
</contrib-group>
<aff id="AFF1"><label>1</label>Department of Epidemiology and Biostatistics, Key Laboratory of Environmental Health of Ministry of Education, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, PR China</aff>
<aff id="AFF2"><label>2</label>Department of Biochemistry and Molecular Biology, The University of Texas Health Science Center at Houston McGovern Medical School, Houston, TX 77030, USA</aff>
<aff id="AFF3"><label>3</label>Department of Bioinformatics and Systems Biology, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, Hubei 430074, PR China</aff>
<aff id="AFF4"><label>4</label>Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA</aff>
<author-notes>
<corresp id="COR1">To whom correspondence should be addressed. Tel: +86 27 8365 0744; Email: <email>gongj@hust.edu.cn</email>. Correspondence may also be addressed to Xiaoping Miao. Tel: +86 27 8365 0744; Email: <email>miaoxp@mail.hust.edu.cn</email>. Correspondence may also be addressed to Lixia Diao. Email: <email>ldiao@mdanderson.org</email>. Correspondence may also be addressed to Leng Han. Tel: +1 713 500 6039; Email: <email>leng.han@uth.tmc.edu</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<day>08</day>
<month>1</month>
<year>2019</year>
</pub-date>
<pub-date iso-8601-date="2018-09-07" pub-type="epub">
<day>07</day>
<month>9</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>07</day>
<month>9</month>
<year>2018</year>
</pub-date>
<!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. -->
<volume>47</volume>
<issue>Database issue</issue>
<issue-title>Database issue</issue-title>
<fpage>D1066</fpage>
<lpage>D1072</lpage>
<history>
<date date-type="accepted">
<day>30</day>
<month>8</month>
<year>2018</year>
</date>
<date date-type="rev-recd">
<day>22</day>
<month>8</month>
<year>2018</year>
</date>
<date date-type="received">
<day>23</day>
<month>7</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s) 2018. Published by Oxford University Press on behalf of Nucleic Acids Research.</copyright-statement>
<copyright-year>2019</copyright-year>
<license license-type="cc-by" xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>
<self-uri xlink:href="gky814.pdf"></self-uri>
<abstract>
<title>Abstract</title>
<p>DNA methylation is an important epigenetic mechanism for regulating gene expression. Aberrant DNA methylation has been observed in various human diseases, including cancer. Single-nucleotide polymorphisms can contribute to tumor initiation, progression and prognosis by influencing DNA methylation, and DNA methylation quantitative trait loci (meQTL) have been identified in physiological and pathological contexts. However, no database has been developed to systematically analyze meQTLs across multiple cancer types. Here, we present Pancan-meQTL, a database to comprehensively provide meQTLs across 23 cancer types from The Cancer Genome Atlas by integrating genome-wide genotype and DNA methylation data. In total, we identified 8 028 964 <italic>cis</italic>-meQTLs and 965 050 <italic>trans</italic>-meQTLs. Among these, 23 432 meQTLs are associated with patient overall survival times. Furthermore, we identified 2 214 458 meQTLs that overlap with known loci identified through genome-wide association studies. Pancan-meQTL provides a user-friendly web interface (<ext-link ext-link-type="uri" xlink:href="http://bioinfo.life.hust.edu.cn/Pancan-meQTL/">http://bioinfo.life.hust.edu.cn/Pancan-meQTL/</ext-link>) that is convenient for browsing, searching and downloading data of interest. This database is a valuable resource for investigating the roles of genetics and epigenetics in cancer.</p>
</abstract>
<funding-group>
<award-group award-type="grant">
<funding-source>
<named-content content-type="funder-name">Cancer Prevention &amp; Research Institute of Texas</named-content>
<named-content content-type="funder-identifier">10.13039/100004917</named-content>
</funding-source>
<award-id>RR150085</award-id>
</award-group>
</funding-group>
<counts>
<page-count count="7"></page-count>
</counts>
</article-meta>
</front>
<body>
<sec id="SEC1" sec-type="intro">
<title>INTRODUCTION</title>
<p>The interpretation of the function of genomic variants, particularly in non-coding regions, is a major challenge for the genetic dissection of complex diseases such as cancer (<xref ref-type="bibr" rid="B1">1</xref>). Genome-wide association studies (GWAS) have identified numerous genetic loci that influence the risk of human cancer (<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B3">3</xref>), but most of these loci are located in non-coding regions and are without clear molecular mechanisms that contribute to the phenotypic outcome. Previous studies considered a diverse set of functional regions, including miRNA binding sites, protein modification sites and transcription factor binding sites (<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B5">5</xref>). However, the link between variants and epigenetic signals involved in the regulation of key biological processes has been largely overlooked.</p>
<p>As a major epigenetic mechanism that directs gene expression, DNA methylation plays a key role in the regulation of crucial biological and pathological processes (<xref ref-type="bibr" rid="B6">6</xref>). Aberrant DNA methylation is frequently observed in various cancers (<xref ref-type="bibr" rid="B7">7</xref>) and represents an attractive biomarker and therapeutic target (<xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B9">9</xref>). Increasing evidence indicates that single-nucleotide polymorphisms (SNPs) contribute to tumor initiation, progression and prognosis by influencing DNA methylation levels (<xref ref-type="bibr" rid="B10">10</xref>,<xref ref-type="bibr" rid="B11">11</xref>). Therefore, DNA methylation may be an important molecular-level phenotype that links a genotype with the trait of a complex disease. It is fundamentally vital to build a public data repository to identify SNPs that significantly affect DNA methylation levels, i.e. methylation quantitative trait loci (meQTL). Recent methodological advances allow for genome-wide screening of meQTLs in different tissues, including blood (<xref ref-type="bibr" rid="B12">12</xref>), lung (<xref ref-type="bibr" rid="B13">13</xref>) and brain (<xref ref-type="bibr" rid="B14">14</xref>). However, no database has been developed to systematically analyze meQTLs across multiple cancer types.</p>
<p>The Cancer Genome Atlas (TCGA) provides genome-wide genotype data and DNA methylation data for ∼10 000 cancer samples, making it possible to systematically conduct meQTL analysis across cancer types. We identified millions of meQTLs across 23 cancer types and have made them available for browsing, searching and downloading through Pancan-meQTL (<ext-link ext-link-type="uri" xlink:href="http://bioinfo.life.hust.edu.cn/Pancan-meQTL/">http://bioinfo.life.hust.edu.cn/Pancan-meQTL/</ext-link>), a database for systematic evaluation of the effects of genetic variants on DNA methylation across diverse cancer types.</p>
</sec>
<sec id="SEC2">
<title>DATA COLLECTION AND PROCESSING</title>
<sec id="SEC2-1">
<title>Genotype data collection, imputation and processing</title>
<p>We downloaded genotype data (level 2) from TCGA data portal (<ext-link ext-link-type="uri" xlink:href="https://portal.gdc.cancer.gov/">https://portal.gdc.cancer.gov/</ext-link>) (Figure <xref ref-type="fig" rid="F1">1A</xref>). We kept 7735 samples with both genotype data and methylation data. We then combined colon adenocarcinoma (COAD) and rectum adenocarcinoma (READ) as colorectal cancer (CRC) (<xref ref-type="bibr" rid="B15">15</xref>) and removed cancer types with sample size &lt;100 primary tumor samples. Thus, for further analysis, we had 7242 samples across 23 cancer types. We performed genotype imputation and filtering per cancer type as described in our previous study (<xref ref-type="bibr" rid="B16">16</xref>). After imputation and quality filtering, on average, 4 318 218 genotypes per cancer type were included in the meQTL analysis.</p>
<fig id="F1" orientation="portrait" position="float">
<label>Figure 1.</label>
<caption>
<p>Data collection, processing and database construction. Pancan-meQTL collected the genotype, methylation and clinical data from TCGA to evaluate the effects of SNPs on methylation levels. For each cancer type, the data were processed using a series of filtering and quality control steps. Four datasets, <italic>cis</italic>-meQTLs, <italic>trans</italic>-meQTLs, survival-meQTLs and GWAS-meQTLs, are included in the database.</p>
</caption>
<graphic xlink:href="gky814fig1"></graphic>
</fig>
</sec>
<sec id="SEC2-2">
<title>Methylation data collection and processing</title>
<p>Methylation beta values (level 3) obtained from TCGA data portal (<ext-link ext-link-type="uri" xlink:href="https://gdc-portal.nci.nih.gov/">https://gdc-portal.nci.nih.gov/</ext-link>) were measured by the Illumina Infinium HumanMethylation450 BeadChip array, which contained 485 512 probes for each sample. Due to the specific nature of methylation patterns on sex chromosomes (<xref ref-type="bibr" rid="B17">17</xref>), we focused on autosomes. In each cancer type, probes were filtered by the following criteria: (i) methylation beta value missing rate &gt; 0.05, (ii) mapping to multiple locations on the genome (<xref ref-type="bibr" rid="B18">18</xref>) and (iii) containing known SNP (1000 Genome Phase3 (<xref ref-type="bibr" rid="B19">19</xref>), MAF &gt; 0.01) at CpG sites (<xref ref-type="bibr" rid="B20">20</xref>,<xref ref-type="bibr" rid="B21">21</xref>) (Figure <xref ref-type="fig" rid="F1">1B</xref>). On average, 369 244 high-quality methylation probes per cancer type were used for analyses. To minimize the effects of outliers on the regression scores, the values for each probe across samples per cancer type were transformed into a standard normal distribution based on rank (<xref ref-type="bibr" rid="B17">17</xref>,<xref ref-type="bibr" rid="B22">22</xref>,<xref ref-type="bibr" rid="B23">23</xref>).</p>
</sec>
<sec id="SEC2-3">
<title>Covariates</title>
<p>To correct for known and unknown confounders and increase the sensitivity of our analyses, we included several covariates. The top five principal components calculated by smartpca in the EIGENSOFT program (<xref ref-type="bibr" rid="B24">24</xref>) were included to control for ethnicity differences. To remove hidden batch effects and other confounders in the methylation data, we used PEER software (<xref ref-type="bibr" rid="B25">25</xref>) to select the first 15 PEER factors from the methylation data as covariates. We included the common confounders of age, sex, and tumor stage as additional covariates (<xref ref-type="bibr" rid="B21">21</xref>,<xref ref-type="bibr" rid="B23">23</xref>,<xref ref-type="bibr" rid="B26">26</xref>).</p>
</sec>
<sec id="SEC2-4">
<title>Identification of meQTLs</title>
<p>Identification of meQTL is straightforward that to test whether individuals carrying different genotypes show different methylation levels (<xref ref-type="bibr" rid="B17">17</xref>,<xref ref-type="bibr" rid="B20">20</xref>,<xref ref-type="bibr" rid="B27">27</xref>,<xref ref-type="bibr" rid="B28">28</xref>). For each cancer type, we performed linear regression with MatrixEQTL (<xref ref-type="bibr" rid="B29">29</xref>) to determine the effects of genetic variation on methylation levels. We calculated the pairwise associations between each SNP and CpG site. We used HumanMethylation450 BeadChip array annotation to extract the location (hg19) of methylation probes. We downloaded the SNP location (hg19) from dbSNP (<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/projects/SNP/">https://www.ncbi.nlm.nih.gov/projects/SNP/</ext-link>). We defined meQTLs as SNPs with false discovery rates (FDRs) calculated by MatrixEQTL &lt;0.05 and the absolute value of correlation coefficient (<italic>r</italic>) ≥0.3. If the SNP was within 1 Mb from the probe location (<xref ref-type="bibr" rid="B22">22</xref>), we denoted it as <italic>cis</italic>-meQTL; and if the SNP was beyond that point, we denoted it as <italic>trans</italic>-meQTL.</p>
</sec>
<sec id="SEC2-5">
<title>Identification of survival-associated meQTLs</title>
<p>To prioritize promising meQTLs, we identified meQTLs that may be associated with patient survival times. We downloaded the clinical data, including patient overall survival times, from TCGA data portal (<ext-link ext-link-type="uri" xlink:href="https://gdc-portal.nci.nih.gov/">https://gdc-portal.nci.nih.gov/</ext-link>). For each meQTL, we used the log-rank test to examine the association between genotypes and patient overall survival times. We plotted Kaplan–Meier (KM) curves to show the survival times for individuals carrying different genotypes. We defined meQTLs with FDR &lt;0.05 as survival-meQTLs.</p>
</sec>
<sec id="SEC2-6">
<title>Identification of meQTLs in GWAS regions</title>
<p>Risk SNPs identified in GWAS studies were downloaded from GWAS catalog (<ext-link ext-link-type="uri" xlink:href="http://www.ebi.ac.uk/gwas/">http://www.ebi.ac.uk/gwas/</ext-link>) (<xref ref-type="bibr" rid="B2">2</xref>). GWAS linkage disequilibrium (LD) regions were extracted from SNAP (<ext-link ext-link-type="uri" xlink:href="https://personal.broadinstitute.org/plin/snap/ldsearch.php">https://personal.broadinstitute.org/plin/snap/ldsearch.php</ext-link>) (<xref ref-type="bibr" rid="B30">30</xref>) with parameters (SNP data set: 1000 Genomes Pilot 1; LD <italic>r</italic><sup>2</sup> threshold: 0.5; population panel: CEU; distance limit: 500 kb). The meQTLs that overlapped with GWAS tagSNPs and LD SNPs were identified as GWAS-meQTLs.</p>
</sec>
<sec id="SEC2-7">
<title>Enrichment analysis</title>
<p>To assess the enrichment of meQTLs in DNA regulatory elements and GWAS loci, we generated a control data set of non-meQTL SNPs with minor allele frequency (MAF) and distance matched to the set of meQTLs for each cancer type. We downloaded transcription factor binding sites (TFBSs) of related ENCODE cell lines from the UCSC genome browser, and extracted cancer-specific GWAS loci from GWAS catalog. Enrichment analyses of meQTLs were performed by two-tailed Fisher's exact test with the following 2 × 2 table: columns; meQTL SNPs and non-meQTL SNPs, rows; SNPs within and not within the TFBSs/GWAS loci.</p>
</sec>
</sec>
<sec id="SEC3">
<title>DATABASE CONTENT AND USAGE</title>
<sec id="SEC3-1">
<title>Samples in Pancan-meQTL</title>
<p>Pancan-meQTL included 23 cancer types with sample size ≥100 in TCGA, covering 7242 tumor samples. The sample size of each cancer type ranged from 103 in skin cutaneous melanoma (SKCM) to 664 in breast invasive carcinoma (BRCA) (Table <xref ref-type="table" rid="tbl1">1</xref>). For the genotype data, we obtained a median of 4 487 756 SNPs for each cancer type after imputation and quality control, ranging from 2 721 411 for BRCA to 5 121 896 for acute myeloid leukemia (LAML). For the methylation data, there were, on average, 384 903 probes for each cancer type after probe filtering and quality control. The range was from 380 594 for CRC to 385 618 for testicular germ cell tumors (TGCT).</p>
<table-wrap id="tbl1" orientation="portrait" position="float">
<label>Table 1.</label>
<caption>
<p>Overview of samples and meQTLs in Pancan-meQTL</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1"></th>
<th align="left" colspan="1" rowspan="1"></th>
<th align="left" colspan="1" rowspan="1"></th>
<th align="left" colspan="1" rowspan="1"></th>
<th align="left" colspan="1" rowspan="1"></th>
<th align="center" colspan="3" rowspan="1">
<italic>Cis</italic>
</th>
<th align="center" colspan="3" rowspan="1">
<italic>Trans</italic>
</th>
</tr>
<tr>
<th align="left" colspan="1" rowspan="1">Cancer type</th>
<th align="left" colspan="1" rowspan="1">Disease full name</th>
<th align="left" colspan="1" rowspan="1">No. of samples</th>
<th align="left" colspan="1" rowspan="1">No. of methylation probes</th>
<th align="left" colspan="1" rowspan="1">No. of genotypes</th>
<th align="left" colspan="1" rowspan="1">Pairs</th>
<th align="left" colspan="1" rowspan="1">meProbes<sup>a</sup></th>
<th align="left" colspan="1" rowspan="1">
<italic>cis</italic>_meQTLs</th>
<th align="left" colspan="1" rowspan="1">Pairs</th>
<th align="left" colspan="1" rowspan="1">meProbes<sup>a</sup></th>
<th align="left" colspan="1" rowspan="1">meQTLs</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">BLCA</td>
<td align="left" colspan="1" rowspan="1">Bladder urothelial carcinoma</td>
<td align="left" colspan="1" rowspan="1">405</td>
<td align="left" colspan="1" rowspan="1">384903</td>
<td align="left" colspan="1" rowspan="1">4182865</td>
<td align="left" colspan="1" rowspan="1">502774</td>
<td align="left" colspan="1" rowspan="1">8136</td>
<td align="left" colspan="1" rowspan="1">301392</td>
<td align="left" colspan="1" rowspan="1">216341</td>
<td align="left" colspan="1" rowspan="1">46165</td>
<td align="left" colspan="1" rowspan="1">51295</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">BRCA</td>
<td align="left" colspan="1" rowspan="1">Breast invasive carcinoma</td>
<td align="left" colspan="1" rowspan="1">664</td>
<td align="left" colspan="1" rowspan="1">384084</td>
<td align="left" colspan="1" rowspan="1">2721411</td>
<td align="left" colspan="1" rowspan="1">340881</td>
<td align="left" colspan="1" rowspan="1">7289</td>
<td align="left" colspan="1" rowspan="1">203391</td>
<td align="left" colspan="1" rowspan="1">47355</td>
<td align="left" colspan="1" rowspan="1">1804</td>
<td align="left" colspan="1" rowspan="1">31118</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">CESC</td>
<td align="left" colspan="1" rowspan="1">Cervical squamous cell carcinoma and endocervical adenocarcinoma</td>
<td align="left" colspan="1" rowspan="1">290</td>
<td align="left" colspan="1" rowspan="1">383425</td>
<td align="left" colspan="1" rowspan="1">4289322</td>
<td align="left" colspan="1" rowspan="1">531458</td>
<td align="left" colspan="1" rowspan="1">11284</td>
<td align="left" colspan="1" rowspan="1">318082</td>
<td align="left" colspan="1" rowspan="1">212025</td>
<td align="left" colspan="1" rowspan="1">48741</td>
<td align="left" colspan="1" rowspan="1">46185</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">CRC</td>
<td align="left" colspan="1" rowspan="1">Colon adenocarcinoma + Rectum adenocarcinoma</td>
<td align="left" colspan="1" rowspan="1">354</td>
<td align="left" colspan="1" rowspan="1">380594</td>
<td align="left" colspan="1" rowspan="1">3879590</td>
<td align="left" colspan="1" rowspan="1">555556</td>
<td align="left" colspan="1" rowspan="1">10781</td>
<td align="left" colspan="1" rowspan="1">316517</td>
<td align="left" colspan="1" rowspan="1">185943</td>
<td align="left" colspan="1" rowspan="1">40872</td>
<td align="left" colspan="1" rowspan="1">55402</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">ESCA</td>
<td align="left" colspan="1" rowspan="1">Esophageal carcinoma</td>
<td align="left" colspan="1" rowspan="1">173</td>
<td align="left" colspan="1" rowspan="1">382712</td>
<td align="left" colspan="1" rowspan="1">4357977</td>
<td align="left" colspan="1" rowspan="1">408020</td>
<td align="left" colspan="1" rowspan="1">15726</td>
<td align="left" colspan="1" rowspan="1">260629</td>
<td align="left" colspan="1" rowspan="1">21790</td>
<td align="left" colspan="1" rowspan="1">5427</td>
<td align="left" colspan="1" rowspan="1">13297</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">HNSC</td>
<td align="left" colspan="1" rowspan="1">Head and neck squamous cell carcinoma</td>
<td align="left" colspan="1" rowspan="1">501</td>
<td align="left" colspan="1" rowspan="1">385146</td>
<td align="left" colspan="1" rowspan="1">4245789</td>
<td align="left" colspan="1" rowspan="1">706915</td>
<td align="left" colspan="1" rowspan="1">10590</td>
<td align="left" colspan="1" rowspan="1">392427</td>
<td align="left" colspan="1" rowspan="1">100579</td>
<td align="left" colspan="1" rowspan="1">16599</td>
<td align="left" colspan="1" rowspan="1">51195</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">KIRC</td>
<td align="left" colspan="1" rowspan="1">Kidney renal clear cell carcinoma</td>
<td align="left" colspan="1" rowspan="1">306</td>
<td align="left" colspan="1" rowspan="1">384916</td>
<td align="left" colspan="1" rowspan="1">4487756</td>
<td align="left" colspan="1" rowspan="1">827668</td>
<td align="left" colspan="1" rowspan="1">14184</td>
<td align="left" colspan="1" rowspan="1">455287</td>
<td align="left" colspan="1" rowspan="1">598701</td>
<td align="left" colspan="1" rowspan="1">95277</td>
<td align="left" colspan="1" rowspan="1">82497</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">KIRP</td>
<td align="left" colspan="1" rowspan="1">Kidney renal papillary cell carcinoma</td>
<td align="left" colspan="1" rowspan="1">271</td>
<td align="left" colspan="1" rowspan="1">384786</td>
<td align="left" colspan="1" rowspan="1">4827856</td>
<td align="left" colspan="1" rowspan="1">830528</td>
<td align="left" colspan="1" rowspan="1">14986</td>
<td align="left" colspan="1" rowspan="1">486170</td>
<td align="left" colspan="1" rowspan="1">232041</td>
<td align="left" colspan="1" rowspan="1">52484</td>
<td align="left" colspan="1" rowspan="1">58017</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">LAML</td>
<td align="left" colspan="1" rowspan="1">Acute myeloid leukemia</td>
<td align="left" colspan="1" rowspan="1">122</td>
<td align="left" colspan="1" rowspan="1">385529</td>
<td align="left" colspan="1" rowspan="1">5121896</td>
<td align="left" colspan="1" rowspan="1">408043</td>
<td align="left" colspan="1" rowspan="1">10758</td>
<td align="left" colspan="1" rowspan="1">283314</td>
<td align="left" colspan="1" rowspan="1">22473</td>
<td align="left" colspan="1" rowspan="1">606</td>
<td align="left" colspan="1" rowspan="1">17201</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">LGG</td>
<td align="left" colspan="1" rowspan="1">Lower grade glioma</td>
<td align="left" colspan="1" rowspan="1">487</td>
<td align="left" colspan="1" rowspan="1">385198</td>
<td align="left" colspan="1" rowspan="1">4611830</td>
<td align="left" colspan="1" rowspan="1">789126</td>
<td align="left" colspan="1" rowspan="1">11092</td>
<td align="left" colspan="1" rowspan="1">454090</td>
<td align="left" colspan="1" rowspan="1">151792</td>
<td align="left" colspan="1" rowspan="1">24257</td>
<td align="left" colspan="1" rowspan="1">61737</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">LIHC</td>
<td align="left" colspan="1" rowspan="1">Liver hepatocellular carcinoma</td>
<td align="left" colspan="1" rowspan="1">367</td>
<td align="left" colspan="1" rowspan="1">383962</td>
<td align="left" colspan="1" rowspan="1">4152031</td>
<td align="left" colspan="1" rowspan="1">449509</td>
<td align="left" colspan="1" rowspan="1">9378</td>
<td align="left" colspan="1" rowspan="1">272962</td>
<td align="left" colspan="1" rowspan="1">127824</td>
<td align="left" colspan="1" rowspan="1">28610</td>
<td align="left" colspan="1" rowspan="1">46149</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">LUAD</td>
<td align="left" colspan="1" rowspan="1">Lung adenocarcinoma</td>
<td align="left" colspan="1" rowspan="1">448</td>
<td align="left" colspan="1" rowspan="1">384670</td>
<td align="left" colspan="1" rowspan="1">4343043</td>
<td align="left" colspan="1" rowspan="1">525439</td>
<td align="left" colspan="1" rowspan="1">8848</td>
<td align="left" colspan="1" rowspan="1">297745</td>
<td align="left" colspan="1" rowspan="1">110266</td>
<td align="left" colspan="1" rowspan="1">19790</td>
<td align="left" colspan="1" rowspan="1">52156</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">LUSC</td>
<td align="left" colspan="1" rowspan="1">Lung squamous cell carcinoma</td>
<td align="left" colspan="1" rowspan="1">359</td>
<td align="left" colspan="1" rowspan="1">385034</td>
<td align="left" colspan="1" rowspan="1">3676672</td>
<td align="left" colspan="1" rowspan="1">598237</td>
<td align="left" colspan="1" rowspan="1">10039</td>
<td align="left" colspan="1" rowspan="1">334937</td>
<td align="left" colspan="1" rowspan="1">191909</td>
<td align="left" colspan="1" rowspan="1">44240</td>
<td align="left" colspan="1" rowspan="1">60597</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">PAAD</td>
<td align="left" colspan="1" rowspan="1">Pancreatic adenocarcinoma</td>
<td align="left" colspan="1" rowspan="1">177</td>
<td align="left" colspan="1" rowspan="1">382517</td>
<td align="left" colspan="1" rowspan="1">4989296</td>
<td align="left" colspan="1" rowspan="1">903193</td>
<td align="left" colspan="1" rowspan="1">24432</td>
<td align="left" colspan="1" rowspan="1">513599</td>
<td align="left" colspan="1" rowspan="1">120777</td>
<td align="left" colspan="1" rowspan="1">41820</td>
<td align="left" colspan="1" rowspan="1">34727</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">PCPG</td>
<td align="left" colspan="1" rowspan="1">Pheochromocytoma and paraganglioma</td>
<td align="left" colspan="1" rowspan="1">175</td>
<td align="left" colspan="1" rowspan="1">385235</td>
<td align="left" colspan="1" rowspan="1">4701955</td>
<td align="left" colspan="1" rowspan="1">589160</td>
<td align="left" colspan="1" rowspan="1">19388</td>
<td align="left" colspan="1" rowspan="1">385289</td>
<td align="left" colspan="1" rowspan="1">34905</td>
<td align="left" colspan="1" rowspan="1">2175</td>
<td align="left" colspan="1" rowspan="1">23719</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">PRAD</td>
<td align="left" colspan="1" rowspan="1">Prostate adenocarcinoma</td>
<td align="left" colspan="1" rowspan="1">479</td>
<td align="left" colspan="1" rowspan="1">385067</td>
<td align="left" colspan="1" rowspan="1">4801718</td>
<td align="left" colspan="1" rowspan="1">1129044</td>
<td align="left" colspan="1" rowspan="1">16366</td>
<td align="left" colspan="1" rowspan="1">574577</td>
<td align="left" colspan="1" rowspan="1">188046</td>
<td align="left" colspan="1" rowspan="1">46160</td>
<td align="left" colspan="1" rowspan="1">66084</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">SARC</td>
<td align="left" colspan="1" rowspan="1">Sarcoma</td>
<td align="left" colspan="1" rowspan="1">257</td>
<td align="left" colspan="1" rowspan="1">382095</td>
<td align="left" colspan="1" rowspan="1">4083674</td>
<td align="left" colspan="1" rowspan="1">458278</td>
<td align="left" colspan="1" rowspan="1">14059</td>
<td align="left" colspan="1" rowspan="1">287992</td>
<td align="left" colspan="1" rowspan="1">64709</td>
<td align="left" colspan="1" rowspan="1">22198</td>
<td align="left" colspan="1" rowspan="1">24734</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">SKCM</td>
<td align="left" colspan="1" rowspan="1">Skin cutaneous melanoma</td>
<td align="left" colspan="1" rowspan="1">103</td>
<td align="left" colspan="1" rowspan="1">384364</td>
<td align="left" colspan="1" rowspan="1">4838338</td>
<td align="left" colspan="1" rowspan="1">200763</td>
<td align="left" colspan="1" rowspan="1">6689</td>
<td align="left" colspan="1" rowspan="1">150232</td>
<td align="left" colspan="1" rowspan="1">8399</td>
<td align="left" colspan="1" rowspan="1">399</td>
<td align="left" colspan="1" rowspan="1">6332</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">STAD</td>
<td align="left" colspan="1" rowspan="1">Stomach adenocarcinoma</td>
<td align="left" colspan="1" rowspan="1">367</td>
<td align="left" colspan="1" rowspan="1">383290</td>
<td align="left" colspan="1" rowspan="1">4265676</td>
<td align="left" colspan="1" rowspan="1">687004</td>
<td align="left" colspan="1" rowspan="1">10723</td>
<td align="left" colspan="1" rowspan="1">382962</td>
<td align="left" colspan="1" rowspan="1">77711</td>
<td align="left" colspan="1" rowspan="1">9612</td>
<td align="left" colspan="1" rowspan="1">49489</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">TGCT</td>
<td align="left" colspan="1" rowspan="1">Testicular germ cell tumors</td>
<td align="left" colspan="1" rowspan="1">148</td>
<td align="left" colspan="1" rowspan="1">385618</td>
<td align="left" colspan="1" rowspan="1">4807863</td>
<td align="left" colspan="1" rowspan="1">470576</td>
<td align="left" colspan="1" rowspan="1">14871</td>
<td align="left" colspan="1" rowspan="1">309018</td>
<td align="left" colspan="1" rowspan="1">36183</td>
<td align="left" colspan="1" rowspan="1">3791</td>
<td align="left" colspan="1" rowspan="1">25912</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">THCA</td>
<td align="left" colspan="1" rowspan="1">Thyroid carcinoma</td>
<td align="left" colspan="1" rowspan="1">498</td>
<td align="left" colspan="1" rowspan="1">385449</td>
<td align="left" colspan="1" rowspan="1">4842972</td>
<td align="left" colspan="1" rowspan="1">830377</td>
<td align="left" colspan="1" rowspan="1">11908</td>
<td align="left" colspan="1" rowspan="1">477575</td>
<td align="left" colspan="1" rowspan="1">248274</td>
<td align="left" colspan="1" rowspan="1">36261</td>
<td align="left" colspan="1" rowspan="1">72317</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">THYM</td>
<td align="left" colspan="1" rowspan="1">Thymoma</td>
<td align="left" colspan="1" rowspan="1">120</td>
<td align="left" colspan="1" rowspan="1">385609</td>
<td align="left" colspan="1" rowspan="1">4940146</td>
<td align="left" colspan="1" rowspan="1">562478</td>
<td align="left" colspan="1" rowspan="1">17015</td>
<td align="left" colspan="1" rowspan="1">352356</td>
<td align="left" colspan="1" rowspan="1">28228</td>
<td align="left" colspan="1" rowspan="1">1981</td>
<td align="left" colspan="1" rowspan="1">22009</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">UCEC</td>
<td align="left" colspan="1" rowspan="1">Uterine corpus endometrial carcinoma</td>
<td align="left" colspan="1" rowspan="1">171</td>
<td align="left" colspan="1" rowspan="1">385407</td>
<td align="left" colspan="1" rowspan="1">4961809</td>
<td align="left" colspan="1" rowspan="1">314774</td>
<td align="left" colspan="1" rowspan="1">14181</td>
<td align="left" colspan="1" rowspan="1">218421</td>
<td align="left" colspan="1" rowspan="1">17953</td>
<td align="left" colspan="1" rowspan="1">2911</td>
<td align="left" colspan="1" rowspan="1">12881</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="T1TFN1">
<p>
<sup>a</sup>meProbes: methylation probes regulated by meQTLs.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="SEC3-2">
<title>meQTLs in Pancan-meQTL</title>
<p>Per cancer type, the associations between each SNP and methylation probe were analyzed for <italic>cis</italic>- and <italic>trans</italic>-meQTL mapping by linear regression with adjusted covariates. In the <italic>cis</italic>-meQTL analysis, we identified a total of 13 619 801 meQTL-CpG pairs at FDR &lt; 0.05 and |<italic>r</italic>| ≥0.3 in 23 cancer types, which corresponded to a median <italic>P</italic>-value &lt;4.34 × 10<sup>−7</sup>. We found a total of 8 028 964 <italic>cis</italic>-meQTLs across the cancer types, with a median of 318 082 meQTLs per cancer type, and a range from 150 232 in SKCM to 574 577 in prostate adenocarcinoma (PRAD) (Table <xref ref-type="table" rid="tbl1">1</xref>). These meQTLs control DNA methylation at a median of 11 284 CpG sites per cancer type. On average, 35.1% <italic>cis</italic>-meQTLs are associated with multiple CpG sites. In <italic>trans</italic>-meQTL analysis, we identified 3 044 224 meQTL-CpG pairs at FDR &lt; 0.05 and |<italic>r</italic>| ≥0.3 in 23 cancer types, which corresponded to a median of <italic>P</italic>-value &lt; 1 × 10<sup>−9</sup>. There are 965 050 <italic>trans</italic>-meQTLs, with a median of 46 185 meQTLs per cancer type, and a range from 6332 in SKCM to 82 497 in kidney renal clear cell carcinoma (KIRC) (Table <xref ref-type="table" rid="tbl1">1</xref>).</p>
<p>We further identified 23 432 meQTLs associated with patient overall survival times across different cancer types at FDR &lt; 0.05. The number of survival-meQTLs ranged from 218 in BRCA to 11 212 in PRAD. We compared meQTL results to GWAS data and found 2 214 458 meQTLs that overlap with GWAS linkage disequilibrium regions of one or multiple traits. Enrichment analyses showed that meQTLs are significant enriched in most of TFBSs, such as CTCF, SIN3AK20 and NRSF (<xref ref-type="supplementary-material" rid="sup1">Supplementary Figure S1</xref>) and GWAS loci (<xref ref-type="supplementary-material" rid="sup1">Supplementary Table S1</xref>).</p>
</sec>
</sec>
<sec id="SEC4">
<title>WEB DESIGN AND INTERFACE</title>
<p>The database was built based on Apache, MySQL, PHP and Javascripts (Figure <xref ref-type="fig" rid="F1">1C</xref>). A user-friendly web interface is provided to facilitate searching, browsing and downloading.</p>
<sec id="SEC4-1">
<title>Querying meQTLs</title>
<p>We provide several entries for querying. Pancan-meQTL contains four datasets: <italic>cis</italic>-meQTLs, <italic>trans</italic>-meQTLs, survival-meQTLs and GWAS-meQTLs (Figure <xref ref-type="fig" rid="F2">2A</xref> and <xref ref-type="fig" rid="F2">B</xref>). We developed four corresponding pages to display each dataset (Figure <xref ref-type="fig" rid="F2">2A</xref>). Users can enter each page from the browser bar to query SNPs, methylation data, and methylation-related genes of interest. On the ‘home’ page, we set a search section for users to query the four meQTL datasets. Also from the home page, users can search results by cancer type from the corresponding cancer type diagram. A quick search option is available on each page (top right) for searching by SNP ID, methylation probe or methylation-related gene symbol. Moreover, we provide a batch search page on the ‘Pancan-meQTLs’ page (Figure <xref ref-type="fig" rid="F2">2C</xref>). On this page, users can input multiple SNPs, methylation probes or genes of interest. A heatmap will show all the <italic>r</italic> values across all analyzed cancer types. For example, with inputs of ‘rs11047888’ and ‘rs4975682’, our results show that rs11044788 has significant correlations with cg11559192 and cg25763538 in 17 and 16 cancer types, respectively; whereas rs4975682 correlates with cg14565270 and cg03265642 in two and six cancer types, respectively (Figure <xref ref-type="fig" rid="F2">2D</xref>).</p>
<fig id="F2" orientation="portrait" position="float">
<label>Figure 2.</label>
<caption>
<p>Overview of Pancan-meQTL database. (<bold>A</bold>) Browser bar, with a quick search box on the right. (<bold>B</bold>) Four modules in Pancan-meQTL: <italic>cis</italic>-meQTLs, <italic>trans</italic>-meQTLs, survival-associated meQTLs and GWAS-related meQTLs. (<bold>C</bold>) Batch search box allows users to input multiple SNPs, methylation probes and genes of interest. (<bold>D</bold>) Example of heatmap in pancan-meQTLs page showing the correlation coefficient across cancer types. (<bold>E</bold>) Records of <italic>cis</italic>-meQTLs on <italic>cis</italic>-meQTLs page. (<bold>F</bold>) Example of meQTL boxplot. (<bold>G</bold>) Records of survival-meQTLs on survival-meQTLs page. (<bold>H</bold>) Example of a Kaplan–Meier plot on survival-meQTL page.</p>
</caption>
<graphic xlink:href="gky814fig2"></graphic>
</fig>
<p>Querying on the <italic>cis/trans</italic>-meQTL page, a table with SNP ID, SNP genomic position, SNP alleles, methylation probe, methylation position, methylation-related gene symbol, gene position, beta value (effect size of SNP on gene expression), <italic>r</italic> value and <italic>P</italic>-value of meQTL will be returned (Figure <xref ref-type="fig" rid="F2">2E</xref>). For each record, a vector diagram of boxplot is provided to display the association between SNP genotypes and methylation levels (Figure <xref ref-type="fig" rid="F2">2F</xref>).</p>
<p>Querying on the survival-meQTL page, details with SNP ID, SNP genomic position, SNP alleles, log-rank test <italic>P</italic>-value and median survival times of different genotypes will be displayed (Figure <xref ref-type="fig" rid="F2">2G</xref>). A vector diagram of the KM plot is embedded in each record to display the association between SNP genotypes and overall survival times (Figure <xref ref-type="fig" rid="F2">2H</xref>).</p>
<p>Querying on the GWAS-meQTLs page will return the SNP information, related methylation, gene information and related GWAS traits. Search boxes are designed for retrieving specific cancer types, SNP, methylation probe and gene.</p>
</sec>
<sec id="SEC4-2">
<title>Downloading data and figures</title>
<p>All the <italic>cis/trans</italic>-meQTLs for each cancer type can be downloaded from the ‘Download’ page. The queried results can be downloaded from the query page by clicking the ‘Download’ button. The <italic>r</italic> values of the batch search can be downloaded from the ‘Pancan-meQTL’ page. The vector diagrams of the boxplot and KM plot can be downloaded from the <italic>cis/trans</italic>-meQTL and survival-meQTL pages, respectively.</p>
</sec>
<sec id="SEC4-3">
<title>Help section</title>
<p>The ‘Help’ page provides information for data collection, processing, result summary and contact. Pancan-meQTL welcomes any feedback by email to the address provided in the ‘Contact us’ section.</p>
</sec>
</sec>
<sec id="SEC5" sec-type="conclusions">
<title>CONCLUSION</title>
<p>We developed Pancan-meQTL as a resource that provides millions of meQTLs in multiple cancer types. Pancan-meQTL is the first public database that focuses on cancer-specific meQTLs. Our comprehensive analyses across 23 cancer types provide a great opportunity to investigate the patterns of meQTLs among cancer types. Among meQTLs, we also identified abundant meQTLs associated with patient survival time or located in known GWAS loci. These meQTLs are potentially promising candidates for genetic research. The Pancan-meQTL database will be continually updated as large-scale genotypic and methylation data become available. As a comprehensive database that characterizes meQTLs across multiple cancer types, Pancan-meQTL will be valuable for improving the interpretation of cancer risk-associated SNPs identified in genetic studies. It represents an important resource for cancer and epigenetic research.</p>
</sec>
<sec sec-type="supplementary-material">
<title>Supplementary Material</title>
<supplementary-material content-type="local-data" id="sup1">
<label>Supplementary Data</label>
<media xlink:href="gky814_supplemental_files.zip">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
</sec>
</body>
<back>
<ack>
<title>ACKNOWLEDGEMENTS</title>
<p>The authors gratefully acknowledge Xianchun Tu for helping design and debug the website. We thank LeeAnn Chastain for editorial assistance. We thank the support from the Cancer Prevention &amp; Research Institute of Texas (CPRIT RR150085).</p>
</ack>
<sec id="SEC6">
<title>SUPPLEMENTARY DATA</title>
<p>
<ext-link ext-link-type="uri" xlink:href="https://academic.oup.com/nar/article-lookup/doi/10.1093/nar/gky814#supplementary-data">Supplementary Data</ext-link> are available at NAR Online.</p>
</sec>
<sec id="SEC7">
<title>FUNDING</title>
<p>Cancer Prevention &amp; Research Institute of Texas [RR150085 to L.H.]. Funding for open access charge: Cancer Prevention &amp; Research Institute of Texas [RR150085].</p>
<p>
<italic>Conflict of interest statement</italic>. None declared.</p>
</sec>
<ref-list>
<title>REFERENCES</title>
<ref id="B1">
<label>1.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Frazer</surname><given-names>K.A.</given-names></name>, <name name-style="western"><surname>Murray</surname><given-names>S.S.</given-names></name>, <name name-style="western"><surname>Schork</surname><given-names>N.J.</given-names></name>, <name name-style="western"><surname>Topol</surname><given-names>E.J.</given-names></name></person-group>
<article-title>Human genetic variation and its contribution to complex traits</article-title>. <source/>Nat. Rev. Genet.<year>2009</year>; <volume>10</volume>:<fpage>241</fpage>–<lpage>251</lpage>.<pub-id pub-id-type="pmid">19293820</pub-id></mixed-citation>
</ref>
<ref id="B2">
<label>2.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>MacArthur</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Bowler</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Cerezo</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Gil</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Hall</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Hastings</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Junkins</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>McMahon</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Milano</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Morales</surname><given-names>J.</given-names></name><etal></etal></person-group>
<article-title>The new NHGRI-EBI Catalog of published genome-wide association studies (GWAS Catalog)</article-title>. <source/>Nucleic Acids Res.<year>2017</year>; <volume>45</volume>:<fpage>D896</fpage>–<lpage>D901</lpage>.<pub-id pub-id-type="pmid">27899670</pub-id></mixed-citation>
</ref>
<ref id="B3">
<label>3.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Welter</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>MacArthur</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Morales</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Burdett</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Hall</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Junkins</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Klemm</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Flicek</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Manolio</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Hindorff</surname><given-names>L.</given-names></name><etal></etal></person-group>
<article-title>The NHGRI GWAS Catalog, a curated resource of SNP-trait associations</article-title>. <source/>Nucleic Acids Res.<year>2014</year>; <volume>42</volume>:<fpage>D1001</fpage>–<lpage>D1006</lpage>.<pub-id pub-id-type="pmid">24316577</pub-id></mixed-citation>
</ref>
<ref id="B4">
<label>4.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Gong</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Ma</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Guo</surname><given-names>A.Y.</given-names></name></person-group>
<article-title>An update of miRNASNP database for better SNP selection by GWAS data, miRNA expression and online tools</article-title>. <source/>Database (Oxford). <year>2015</year>; <volume>2015</volume>:<fpage>bav029</fpage>.<pub-id pub-id-type="pmid">25877638</pub-id></mixed-citation>
</ref>
<ref id="B5">
<label>5.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Gong</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Tian</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Lou</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Ke</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Gong</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Zhu</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Zou</surname><given-names>D.</given-names></name><etal></etal></person-group>
<article-title>A polymorphic MYC response element in KBTBD11 influences colorectal cancer risk, especially in interaction with an MYC-regulated SNP rs6983267</article-title>. <source/>Ann. Oncol.<year>2018</year>; <volume>29</volume>:<fpage>632</fpage>–<lpage>639</lpage>.<pub-id pub-id-type="pmid">29267898</pub-id></mixed-citation>
</ref>
<ref id="B6">
<label>6.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Schubeler</surname><given-names>D.</given-names></name></person-group>
<article-title>Function and information content of DNA methylation</article-title>. <source/>Nature. <year>2015</year>; <volume>517</volume>:<fpage>321</fpage>–<lpage>326</lpage>.<pub-id pub-id-type="pmid">25592537</pub-id></mixed-citation>
</ref>
<ref id="B7">
<label>7.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Nebbioso</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Tambaro</surname><given-names>F.P.</given-names></name>, <name name-style="western"><surname>Dell’Aversana</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Altucci</surname><given-names>L.</given-names></name></person-group>
<article-title>Cancer epigenetics: moving forward</article-title>. <source/>PLoS Genet.<year>2018</year>; <volume>14</volume>:<fpage>e1007362</fpage>.<pub-id pub-id-type="pmid">29879107</pub-id></mixed-citation>
</ref>
<ref id="B8">
<label>8.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>van Hoesel</surname><given-names>A.Q.</given-names></name>, <name name-style="western"><surname>Sato</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Elashoff</surname><given-names>D.A.</given-names></name>, <name name-style="western"><surname>Turner</surname><given-names>R.R.</given-names></name>, <name name-style="western"><surname>Giuliano</surname><given-names>A.E.</given-names></name>, <name name-style="western"><surname>Shamonki</surname><given-names>J.M.</given-names></name>, <name name-style="western"><surname>Kuppen</surname><given-names>P.J.</given-names></name>, <name name-style="western"><surname>van de Velde</surname><given-names>C.J.</given-names></name>, <name name-style="western"><surname>Hoon</surname><given-names>D.S.</given-names></name></person-group>
<article-title>Assessment of DNA methylation status in early stages of breast cancer development</article-title>. <source/>Br J. Cancer. <year>2013</year>; <volume>108</volume>:<fpage>2033</fpage>–<lpage>2038</lpage>.<pub-id pub-id-type="pmid">23652305</pub-id></mixed-citation>
</ref>
<ref id="B9">
<label>9.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>Q.</given-names></name>, <name name-style="western"><surname>Kang</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Same</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Zhou</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Sun</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>C.C.</given-names></name>, <name name-style="western"><surname>Matsuoka</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Sher</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Wong</surname><given-names>W.H.</given-names></name><etal></etal></person-group>
<article-title>CancerDetector: ultrasensitive and non-invasive cancer detection at the resolution of individual reads using cell-free DNA methylation sequencing data</article-title>. <source/>Nucleic Acids Res.<year>2018</year>; <comment>doi:10.1093/nar/gky423</comment>.</mixed-citation>
</ref>
<ref id="B10">
<label>10.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Heyn</surname><given-names>H.</given-names></name></person-group>
<article-title>Quantitative trait loci identify functional noncoding variation in cancer</article-title>. <source/>PLos Genet.<year>2016</year>; <volume>12</volume>:<fpage>e1005826</fpage>.<pub-id pub-id-type="pmid">26938653</pub-id></mixed-citation>
</ref>
<ref id="B11">
<label>11.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Sung</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>H.H.</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>Q.</given-names></name>, <name name-style="western"><surname>Hu</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Tang</surname><given-names>Z.Z.</given-names></name>, <name name-style="western"><surname>Su</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Ding</surname><given-names>T.</given-names></name><etal></etal></person-group>
<article-title>Common genetic variants in epigenetic machinery genes and risk of upper gastrointestinal cancers</article-title>. <source/>Int. J. Epidemiol.<year>2015</year>; <volume>44</volume>:<fpage>1341</fpage>–<lpage>1352</lpage>.<pub-id pub-id-type="pmid">25921222</pub-id></mixed-citation>
</ref>
<ref id="B12">
<label>12.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Zhernakova</surname><given-names>D.V.</given-names></name>, <name name-style="western"><surname>Deelen</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Vermaat</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>van Iterson</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>van Galen</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Arindrarto</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>van ’t Hof</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Mei</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>van Dijk</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Westra</surname><given-names>H.J.</given-names></name><etal></etal></person-group>
<article-title>Identification of context-dependent expression quantitative trait loci in whole blood</article-title>. <source/>Nat. Genet.<year>2017</year>; <volume>49</volume>:<fpage>139</fpage>–<lpage>145</lpage>.<pub-id pub-id-type="pmid">27918533</pub-id></mixed-citation>
</ref>
<ref id="B13">
<label>13.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Shi</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Marconett</surname><given-names>C.N.</given-names></name>, <name name-style="western"><surname>Duan</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Hyland</surname><given-names>P.L.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Wheeler</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Zhou</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Campan</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>D.S.</given-names></name><etal></etal></person-group>
<article-title>Characterizing the genetic basis of methylome diversity in histologically normal human lung tissue</article-title>. <source/>Nat. Commun.<year>2014</year>; <volume>5</volume>:<fpage>3365</fpage>.<pub-id pub-id-type="pmid">24572595</pub-id></mixed-citation>
</ref>
<ref id="B14">
<label>14.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Gibbs</surname><given-names>J.R.</given-names></name>, <name name-style="western"><surname>van der Brug</surname><given-names>M.P.</given-names></name>, <name name-style="western"><surname>Hernandez</surname><given-names>D.G.</given-names></name>, <name name-style="western"><surname>Traynor</surname><given-names>B.J.</given-names></name>, <name name-style="western"><surname>Nalls</surname><given-names>M.A.</given-names></name>, <name name-style="western"><surname>Lai</surname><given-names>S.L.</given-names></name>, <name name-style="western"><surname>Arepalli</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Dillman</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Rafferty</surname><given-names>I.P.</given-names></name>, <name name-style="western"><surname>Troncoso</surname><given-names>J.</given-names></name><etal></etal></person-group>
<article-title>Abundant quantitative trait loci exist for DNA methylation and gene expression in human brain</article-title>. <source/>PLos Genet.<year>2010</year>; <volume>6</volume>:<fpage>e1000952</fpage>.<pub-id pub-id-type="pmid">20485568</pub-id></mixed-citation>
</ref>
<ref id="B15">
<label>15.</label>
<mixed-citation publication-type="journal">
<collab>Cancer Genome Atlas, N.</collab>
<article-title>Comprehensive molecular characterization of human colon and rectal cancer</article-title>. <source/>Nature. <year>2012</year>; <volume>487</volume>:<fpage>330</fpage>–<lpage>337</lpage>.<pub-id pub-id-type="pmid">22810696</pub-id></mixed-citation>
</ref>
<ref id="B16">
<label>16.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Gong</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Mei</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Xiang</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Ye</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Feng</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Diao</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Guo</surname><given-names>A.Y.</given-names></name><etal></etal></person-group>
<article-title>PancanQTL: systematic identification of cis-eQTLs and trans-eQTLs in 33 cancer types</article-title>. <source/>Nucleic Acids Res.<year>2018</year>; <volume>46</volume>:<fpage>D971</fpage>–<lpage>D976</lpage>.<pub-id pub-id-type="pmid">29036324</pub-id></mixed-citation>
</ref>
<ref id="B17">
<label>17.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>McClay</surname><given-names>J.L.</given-names></name>, <name name-style="western"><surname>Shabalin</surname><given-names>A.A.</given-names></name>, <name name-style="western"><surname>Dozmorov</surname><given-names>M.G.</given-names></name>, <name name-style="western"><surname>Adkins</surname><given-names>D.E.</given-names></name>, <name name-style="western"><surname>Kumar</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Nerella</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Clark</surname><given-names>S.L.</given-names></name>, <name name-style="western"><surname>Bergen</surname><given-names>S.E.</given-names></name>, <name name-style="western"><surname>Swedish Schizophrenia</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Hultman</surname><given-names>C.M.</given-names></name><etal></etal></person-group>
<article-title>High density methylation QTL analysis in human blood via next-generation sequencing of the methylated genomic DNA fraction</article-title>. <source/>Genome Biol.<year>2015</year>; <volume>16</volume>:<fpage>291</fpage>.<pub-id pub-id-type="pmid">26699738</pub-id></mixed-citation>
</ref>
<ref id="B18">
<label>18.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>Y.A.</given-names></name>, <name name-style="western"><surname>Lemire</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Choufani</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Butcher</surname><given-names>D.T.</given-names></name>, <name name-style="western"><surname>Grafodatskaya</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Zanke</surname><given-names>B.W.</given-names></name>, <name name-style="western"><surname>Gallinger</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Hudson</surname><given-names>T.J.</given-names></name>, <name name-style="western"><surname>Weksberg</surname><given-names>R.</given-names></name></person-group>
<article-title>Discovery of cross-reactive probes and polymorphic CpGs in the Illumina Infinium HumanMethylation450 microarray</article-title>. <source/>Epigenetics. <year>2013</year>; <volume>8</volume>:<fpage>203</fpage>–<lpage>209</lpage>.<pub-id pub-id-type="pmid">23314698</pub-id></mixed-citation>
</ref>
<ref id="B19">
<label>19.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><collab>Genomes Project, C.</collab><name name-style="western"><surname>Auton</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Brooks</surname><given-names>L.D.</given-names></name>, <name name-style="western"><surname>Durbin</surname><given-names>R.M.</given-names></name>, <name name-style="western"><surname>Garrison</surname><given-names>E.P.</given-names></name>, <name name-style="western"><surname>Kang</surname><given-names>H.M.</given-names></name>, <name name-style="western"><surname>Korbel</surname><given-names>J.O.</given-names></name>, <name name-style="western"><surname>Marchini</surname><given-names>J.L.</given-names></name>, <name name-style="western"><surname>McCarthy</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>McVean</surname><given-names>G.A.</given-names></name><etal></etal></person-group>
<article-title>A global reference for human genetic variation</article-title>. <source/>Nature. <year>2015</year>; <volume>526</volume>:<fpage>68</fpage>–<lpage>74</lpage>.<pub-id pub-id-type="pmid">26432245</pub-id></mixed-citation>
</ref>
<ref id="B20">
<label>20.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Andrews</surname><given-names>S.V.</given-names></name>, <name name-style="western"><surname>Ellis</surname><given-names>S.E.</given-names></name>, <name name-style="western"><surname>Bakulski</surname><given-names>K.M.</given-names></name>, <name name-style="western"><surname>Sheppard</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Croen</surname><given-names>L.A.</given-names></name>, <name name-style="western"><surname>Hertz-Picciotto</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Newschaffer</surname><given-names>C.J.</given-names></name>, <name name-style="western"><surname>Feinberg</surname><given-names>A.P.</given-names></name>, <name name-style="western"><surname>Arking</surname><given-names>D.E.</given-names></name>, <name name-style="western"><surname>Ladd-Acosta</surname><given-names>C.</given-names></name><etal></etal></person-group>
<article-title>Cross-tissue integration of genetic and epigenetic data offers insight into autism spectrum disorder</article-title>. <source/>Nat. Commun.<year>2017</year>; <volume>8</volume>:<fpage>1011</fpage>.<pub-id pub-id-type="pmid">29066808</pub-id></mixed-citation>
</ref>
<ref id="B21">
<label>21.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Schulz</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Ruppert</surname><given-names>A.K.</given-names></name>, <name name-style="western"><surname>Herms</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Wolf</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Mirza-Schreiber</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Stegle</surname><given-names>O.</given-names></name>, <name name-style="western"><surname>Czamara</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Forstner</surname><given-names>A.J.</given-names></name>, <name name-style="western"><surname>Sivalingam</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Schoch</surname><given-names>S.</given-names></name><etal></etal></person-group>
<article-title>Genome-wide mapping of genetic determinants influencing DNA methylation and gene expression in human hippocampus</article-title>. <source/>Nat. Commun.<year>2017</year>; <volume>8</volume>:<fpage>1511</fpage>.<pub-id pub-id-type="pmid">29142228</pub-id></mixed-citation>
</ref>
<ref id="B22">
<label>22.</label>
<mixed-citation publication-type="journal">
<collab>GTEx Consortium</collab>
<article-title>The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans</article-title>. <source/>Science. <year>2015</year>; <volume>348</volume>:<fpage>648</fpage>–<lpage>660</lpage>.<pub-id pub-id-type="pmid">25954001</pub-id></mixed-citation>
</ref>
<ref id="B23">
<label>23.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Gaunt</surname><given-names>T.R.</given-names></name>, <name name-style="western"><surname>Shihab</surname><given-names>H.A.</given-names></name>, <name name-style="western"><surname>Hemani</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Min</surname><given-names>J.L.</given-names></name>, <name name-style="western"><surname>Woodward</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Lyttleton</surname><given-names>O.</given-names></name>, <name name-style="western"><surname>Zheng</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Duggirala</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>McArdle</surname><given-names>W.L.</given-names></name>, <name name-style="western"><surname>Ho</surname><given-names>K.</given-names></name><etal></etal></person-group>
<article-title>Systematic identification of genetic influences on methylation across the human life course</article-title>. <source/>Genome Biol.<year>2016</year>; <volume>17</volume>:<fpage>61</fpage>.<pub-id pub-id-type="pmid">27036880</pub-id></mixed-citation>
</ref>
<ref id="B24">
<label>24.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Price</surname><given-names>A.L.</given-names></name>, <name name-style="western"><surname>Patterson</surname><given-names>N.J.</given-names></name>, <name name-style="western"><surname>Plenge</surname><given-names>R.M.</given-names></name>, <name name-style="western"><surname>Weinblatt</surname><given-names>M.E.</given-names></name>, <name name-style="western"><surname>Shadick</surname><given-names>N.A.</given-names></name>, <name name-style="western"><surname>Reich</surname><given-names>D.</given-names></name></person-group>
<article-title>Principal components analysis corrects for stratification in genome-wide association studies</article-title>. <source/>Nat. Genet.<year>2006</year>; <volume>38</volume>:<fpage>904</fpage>–<lpage>909</lpage>.<pub-id pub-id-type="pmid">16862161</pub-id></mixed-citation>
</ref>
<ref id="B25">
<label>25.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Stegle</surname><given-names>O.</given-names></name>, <name name-style="western"><surname>Parts</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Piipari</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Winn</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Durbin</surname><given-names>R.</given-names></name></person-group>
<article-title>Using probabilistic estimation of expression residuals (PEER) to obtain increased power and interpretability of gene expression analyses</article-title>. <source/>Nat. Protoc.<year>2012</year>; <volume>7</volume>:<fpage>500</fpage>–<lpage>507</lpage>.<pub-id pub-id-type="pmid">22343431</pub-id></mixed-citation>
</ref>
<ref id="B26">
<label>26.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Ongen</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Andersen</surname><given-names>C.L.</given-names></name>, <name name-style="western"><surname>Bramsen</surname><given-names>J.B.</given-names></name>, <name name-style="western"><surname>Oster</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Rasmussen</surname><given-names>M.H.</given-names></name>, <name name-style="western"><surname>Ferreira</surname><given-names>P.G.</given-names></name>, <name name-style="western"><surname>Sandoval</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Vidal</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Whiffin</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Planchon</surname><given-names>A.</given-names></name><etal></etal></person-group>
<article-title>Putative cis-regulatory drivers in colorectal cancer</article-title>. <source/>Nature. <year>2014</year>; <volume>512</volume>:<fpage>87</fpage>–<lpage>90</lpage>.<pub-id pub-id-type="pmid">25079323</pub-id></mixed-citation>
</ref>
<ref id="B27">
<label>27.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Bonder</surname><given-names>M.J.</given-names></name>, <name name-style="western"><surname>Luijk</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Zhernakova</surname><given-names>D.V.</given-names></name>, <name name-style="western"><surname>Moed</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Deelen</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Vermaat</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>van Iterson</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>van Dijk</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>van Galen</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Bot</surname><given-names>J.</given-names></name><etal></etal></person-group>
<article-title>Disease variants alter transcription factor levels and methylation of their binding sites</article-title>. <source/>Nat. Genet.<year>2017</year>; <volume>49</volume>:<fpage>131</fpage>–<lpage>138</lpage>.<pub-id pub-id-type="pmid">27918535</pub-id></mixed-citation>
</ref>
<ref id="B28">
<label>28.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Jaffe</surname><given-names>A.E.</given-names></name>, <name name-style="western"><surname>Gao</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Deep-Soboslay</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Tao</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Hyde</surname><given-names>T.M.</given-names></name>, <name name-style="western"><surname>Weinberger</surname><given-names>D.R.</given-names></name>, <name name-style="western"><surname>Kleinman</surname><given-names>J.E.</given-names></name></person-group>
<article-title>Mapping DNA methylation across development, genotype and schizophrenia in the human frontal cortex</article-title>. <source/>Nat. Neurosci.<year>2016</year>; <volume>19</volume>:<fpage>40</fpage>–<lpage>47</lpage>.<pub-id pub-id-type="pmid">26619358</pub-id></mixed-citation>
</ref>
<ref id="B29">
<label>29.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Shabalin</surname><given-names>A.A.</given-names></name></person-group>
<article-title>Matrix eQTL: ultra fast eQTL analysis via large matrix operations</article-title>. <source/>Bioinformatics. <year>2012</year>; <volume>28</volume>:<fpage>1353</fpage>–<lpage>1358</lpage>.<pub-id pub-id-type="pmid">22492648</pub-id></mixed-citation>
</ref>
<ref id="B30">
<label>30.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Johnson</surname><given-names>A.D.</given-names></name>, <name name-style="western"><surname>Handsaker</surname><given-names>R.E.</given-names></name>, <name name-style="western"><surname>Pulit</surname><given-names>S.L.</given-names></name>, <name name-style="western"><surname>Nizzari</surname><given-names>M.M.</given-names></name>, <name name-style="western"><surname>O’Donnell</surname><given-names>C.J.</given-names></name>, <name name-style="western"><surname>de Bakker</surname><given-names>P.I.</given-names></name></person-group>
<article-title>SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap</article-title>. <source/>Bioinformatics. <year>2008</year>; <volume>24</volume>:<fpage>2938</fpage>–<lpage>2939</lpage>.<pub-id pub-id-type="pmid">18974171</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>